An elaborate DNA origami tubular nanodevice encapsulating antigens and adjuvants protects mice from cancer through tumour-specific immunomodulation.
References
Hollingsworth, R. E. & Jansen, K. NPJ Vaccines 4, 7 (2019).
Van der Burg, S. H. et al. Nat. Rev. Cancer 16, 219–233 (2016).
Smith, C. C. et al. Nat. Rev. Cancer 19, 465–478 (2019).
Anguille, S. et al. Leukemia 26, 2186–2196 (2012).
Kranz, L. M. et al. Nature 534, 396–401 (2016).
Liu, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-020-0793-6 (2020).
Jiang, Q. et al. Adv. Mater. 31, e1804785 (2019).
Wang, P. F. et al. Chem 2, 359–382 (2017).
Lu, Y., Aimetti, A. A., Langer, R. & Gu, Z. Nat. Rev. Mater. 1, 16075 (2016).
Ott, P. A. et al. Nature 547, 217–221 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Li, H., Gu, Z. Nanodevices for cancer vaccination. Nat. Mater. 20, 286–287 (2021). https://doi.org/10.1038/s41563-021-00941-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-021-00941-4
- Springer Nature Limited